General Information of the Compound
Compound ID
CP0452994
Compound Name
2-[4-(3-Fluoro-pyridin-2-yl)-piperazin-1-ylmethyl]-1H-benzoimidazole
    Show/Hide
Structure
Formula
C17H18FN5
Molecular Weight
311.364
Canonical SMILES
Fc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1
    Show/Hide
InChI
InChI=1S/C17H18FN5/c18-13-4-3-7-19-17(13)23-10-8-22(9-11-23)12-16-20-14-5-1-2-6-15(14)21-16/h1-7H,8-12H2,(H,20,21)
    Show/Hide
InChIKey
DIIMPNOBUZSQDU-UHFFFAOYSA-N
Physicochemical Property
logP
2.4192
Rotatable Bonds
3
Heavy Atom Count
23
Polar Areas
48.05
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9966489
SID: 14943460
ChEMBL ID
CHEMBL126687
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 24 nM
   TI
   LI
   LO
   TS